{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:03:28Z","timestamp":1792461808385,"version":"4.5.0"},"reference-count":169,"publisher":"Bioscientifica","issue":"3","content-domain":{"domain":["jme.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"abstract":"<jats:p>\n                    Islet amyloid polypeptide (IAPP) forms cytotoxic oligomers and amyloid fibrils in islets in type 2 diabetes (T2DM). The causal factors for amyloid formation are largely unknown. Mechanisms of molecular folding and assembly of human IAPP (hIAPP) into \u03b2-sheets, oligomers and fibrils have been assessed by detailed biophysical studies of hIAPP and non-fibrillogenic, rodent IAPP (rIAPP); cytotoxicity is associated with the early phases (oligomers\/multimers) of fibrillogenesis. Interaction with synthetic membranes promotes \u03b2-sheet assembly possibly via a transient \u03b1-helical molecular conformation. Cellular hIAPP cytotoxicity can be activated from intracellular or extracellular sites. In transgenic rodents overexpressing hIAPP, intracellular pro-apoptotic signals can be generated at different points in \u03b2-cell protein synthesis. Increased cellular trafficking of proIAPP, failure of the unfolded protein response (UPR) or excess trafficking of misfolded peptide via the degradation pathways can induce apoptosis; these data indicate that defects in intracellular handling of hIAPP can induce cytotoxicity. However, there is no evidence for IAPP overexpression in T2DM. Extracellular amyloidosis is directly related to the degree of \u03b2-cell apoptosis in islets in T2DM. IAPP fragments, fibrils and multimers interact with membranes causing disruption\n                    <jats:italic>in vivo<\/jats:italic>\n                    and\n                    <jats:italic>in vitro<\/jats:italic>\n                    . These findings support a role for extracellular IAPP in \u03b2-sheet conformation in cytotoxicity. Inhibitors of fibrillogenesis are useful tools to determine the aberrant mechanisms that result in hIAPP molecular refolding and islet amyloidosis. However, currently, their role as therapeutic agents remains uncertain.\n                  <\/jats:p>","DOI":"10.1530\/jme-17-0105","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T20:30:20Z","timestamp":1502829020000},"page":"R121-R140","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-6","source":"Crossref","is-referenced-by-count":138,"title":["The \u03b2-cell assassin: IAPP cytotoxicity"],"prefix":"10.1530","volume":"59","author":[{"given":"Daniel","family":"Raleigh","sequence":"first","affiliation":[{"name":"1Department of Chemistry, Stony Brook University, Stony Brook, New York, USA"},{"name":"2Research Department of Structural and Molecule Biology, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Chemistry, Stony Brook University, Stony Brook, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beno\u00eet","family":"Hastoy","sequence":"additional","affiliation":[{"name":"3Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Clark","sequence":"additional","affiliation":[{"name":"3Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"2017090817102230000_59.3.R121.1","doi-asserted-by":"crossref","first-page":"e12977","DOI":"10.7554\/eLife.12977","article-title":"Time-resolved studies define the nature of toxic IAPP intermediates, providing insight for anti-amyloidosis therapeutics","volume":"5","author":"Abedini","year":"2016","journal-title":"eLife"},{"key":"2017090817102230000_59.3.R121.2","doi-asserted-by":"publisher","DOI":"10.1021\/bi051432v"},{"key":"2017090817102230000_59.3.R121.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2005.10.052"},{"key":"2017090817102230000_59.3.R121.4","doi-asserted-by":"crossref","first-page":"015005","DOI":"10.1088\/1478-3975\/6\/1\/015005","article-title":"A role for helical intermediates in amyloid formation by natively unfolded polypeptides?","volume":"6","author":"Abedini","year":"2009","journal-title":"Physical Biology"},{"key":"2017090817102230000_59.3.R121.5","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1042\/bj20030422","article-title":"Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid","volume":"374","author":"Aitken","year":"2003","journal-title":"Biochemcal Journal"},{"key":"2017090817102230000_59.3.R121.6","doi-asserted-by":"crossref","first-page":"2798269.","DOI":"10.1155\/2016\/2798269","article-title":"Islet amyloid polypeptide: structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"Journal of Diabetes Research"},{"key":"2017090817102230000_59.3.R121.7","doi-asserted-by":"publisher","DOI":"10.2337\/diab.41.4.508"},{"key":"2017090817102230000_59.3.R121.8","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M801383200"},{"key":"2017090817102230000_59.3.R121.9","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2012.81"},{"key":"2017090817102230000_59.3.R121.10","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0970"},{"key":"2017090817102230000_59.3.R121.11","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)81467-X"},{"key":"2017090817102230000_59.3.R121.12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/13506129.2012.679988","article-title":"Extensive amyloid formation in transplanted microencapsulated mouse and human islets","volume":"19","author":"Bohman","year":"2012","journal-title":"Amyloid"},{"key":"2017090817102230000_59.3.R121.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0396"},{"key":"2017090817102230000_59.3.R121.14","doi-asserted-by":"publisher","DOI":"10.1021\/ja1007867"},{"key":"2017090817102230000_59.3.R121.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2010.09.070"},{"key":"2017090817102230000_59.3.R121.16","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.1.102"},{"key":"2017090817102230000_59.3.R121.17","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.6.752"},{"key":"2017090817102230000_59.3.R121.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2012.11.003"},{"key":"2017090817102230000_59.3.R121.19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1305517110"},{"key":"2017090817102230000_59.3.R121.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2011.12.032"},{"key":"2017090817102230000_59.3.R121.21","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0178"},{"key":"2017090817102230000_59.3.R121.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1111-z"},{"key":"2017090817102230000_59.3.R121.23","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.4.612"},{"key":"2017090817102230000_59.3.R121.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0854.2010.01125.x"},{"key":"2017090817102230000_59.3.R121.25","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1386"},{"key":"2017090817102230000_59.3.R121.26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.75.101304.123901"},{"key":"2017090817102230000_59.3.R121.27","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/dmr.5610080204","article-title":"Islet amyloid: an enigma of type 2 diabetes","volume":"8","author":"Clark","year":"1992","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"key":"2017090817102230000_59.3.R121.28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00221649","article-title":"Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects","volume":"257","author":"Clark","year":"1989","journal-title":"Cell and Tissue Research"},{"key":"2017090817102230000_59.3.R121.29","doi-asserted-by":"crossref","unstructured":"Clark A Moffitt J 2007 Pancreatic Amyloid and Diabetes. In Protein Misfolding, Aggregation and Conformational Diseases, pp 199\u2013216. Eds Uversky VN Fibk AL . New York, NY, USA: Springer.","DOI":"10.1007\/978-0-387-36534-3_10"},{"key":"2017090817102230000_59.3.R121.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1304-4"},{"key":"2017090817102230000_59.3.R121.31","first-page":"151","article-title":"Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes","volume":"9","author":"Clark","year":"1988","journal-title":"Diabetes Research"},{"key":"2017090817102230000_59.3.R121.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1562-x"},{"key":"2017090817102230000_59.3.R121.33","doi-asserted-by":"publisher","DOI":"10.1021\/bi051525c"},{"key":"2017090817102230000_59.3.R121.34","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0522"},{"key":"2017090817102230000_59.3.R121.35","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00125-016-4174-2","article-title":"Loss of prohormone convertase 2 promotes beta cell dysfunction in a rodent transplant model expressing human pro-islet amyloid polypeptide","volume":"60","author":"Courtade","year":"2017","journal-title":"Diabetologia"},{"key":"2017090817102230000_59.3.R121.36","doi-asserted-by":"publisher","DOI":"10.1007\/BF00402271"},{"key":"2017090817102230000_59.3.R121.37","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.5.640"},{"key":"2017090817102230000_59.3.R121.38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.18.8467"},{"key":"2017090817102230000_59.3.R121.39","doi-asserted-by":"publisher","DOI":"10.3109\/13506129809007297"},{"key":"2017090817102230000_59.3.R121.40","doi-asserted-by":"publisher","DOI":"10.1038\/nri2925"},{"key":"2017090817102230000_59.3.R121.41","first-page":"49","article-title":"Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals","volume":"38","author":"Ehrlich","year":"1961","journal-title":"American Journal of Pathology"},{"key":"2017090817102230000_59.3.R121.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemphyslip.2009.03.008"},{"key":"2017090817102230000_59.3.R121.43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708354105"},{"key":"2017090817102230000_59.3.R121.44","doi-asserted-by":"publisher","DOI":"10.1021\/ja3031664"},{"key":"2017090817102230000_59.3.R121.45","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400933"},{"key":"2017090817102230000_59.3.R121.46","doi-asserted-by":"publisher","DOI":"10.1021\/ja8097417"},{"key":"2017090817102230000_59.3.R121.47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jinorgbio.2010.05.012","article-title":"Human pro-islet amyloid polypeptide (ProIAPP(1\u201348)) forms amyloid fibrils and amyloid spherulites in vitro","volume":"104","author":"Exley","year":"2010","journal-title":"Journal of Inorganic Biochemistry"},{"key":"2017090817102230000_59.3.R121.48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jcjd.2015.01.291","article-title":"In vitro evaluation of hypoglycemic agents to target human islet amyloid polypeptide: a key protein involved in amyloid deposition and beta-cell loss","volume":"39","author":"Fortin","year":"2015","journal-title":"Canadian Journal of Diabetes"},{"key":"2017090817102230000_59.3.R121.49","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(93)81444-5"},{"key":"2017090817102230000_59.3.R121.50","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3437"},{"key":"2017090817102230000_59.3.R121.51","doi-asserted-by":"crossref","first-page":"256954","DOI":"10.1155\/2008\/256954","article-title":"The role of the 14\u201320 domain of the islet amyloid polypeptide in amyloid formation","volume":"2008","author":"Gilead","year":"2008","journal-title":"Experimental Diabetes Research"},{"key":"2017090817102230000_59.3.R121.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2005.04.017"},{"key":"2017090817102230000_59.3.R121.53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R800016200"},{"key":"2017090817102230000_59.3.R121.54","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198006053022305"},{"key":"2017090817102230000_59.3.R121.55","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)01377-3"},{"key":"2017090817102230000_59.3.R121.56","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/cdd.2017.22","article-title":"Non-apoptotic functions of BCL-2 family proteins","volume":"8","author":"Gross","year":"2017","journal-title":"Cell Death and Differentiation"},{"key":"2017090817102230000_59.3.R121.57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906471106"},{"key":"2017090817102230000_59.3.R121.58","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2182"},{"key":"2017090817102230000_59.3.R121.59","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1210\/me.2015-1255","article-title":"CHOP contributes to, but is not the only mediator of, IAPP induced beta-cell apoptosis","volume":"30","author":"Gurlo","year":"2016","journal-title":"Molecular Endocrinology"},{"key":"2017090817102230000_59.3.R121.60","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2010.090532"},{"key":"2017090817102230000_59.3.R121.61","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0037"},{"key":"2017090817102230000_59.3.R121.62","doi-asserted-by":"publisher","DOI":"10.1007\/BF00408349"},{"key":"2017090817102230000_59.3.R121.63","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/fphys.2017.00005","article-title":"The multifaceted role of SNARE proteins in membrane fusion","volume":"8","author":"Han","year":"2017","journal-title":"Frontiers in Physiology"},{"key":"2017090817102230000_59.3.R121.64","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1038\/s41598-017-03013-3","article-title":"A central small amino acid in the VAMP2 transmembrane domain regulates the fusion pore in exocytosis","volume":"7","author":"Hastoy","year":"2017","journal-title":"Scientific Reports"},{"key":"2017090817102230000_59.3.R121.65","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2000.01548.x"},{"key":"2017090817102230000_59.3.R121.66","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)01287-4"},{"key":"2017090817102230000_59.3.R121.67","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00318.2007"},{"key":"2017090817102230000_59.3.R121.68","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0197"},{"key":"2017090817102230000_59.3.R121.69","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00208.2007"},{"key":"2017090817102230000_59.3.R121.70","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400826"},{"key":"2017090817102230000_59.3.R121.71","doi-asserted-by":"publisher","DOI":"10.1042\/bj2100297"},{"key":"2017090817102230000_59.3.R121.72","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2001.4593"},{"key":"2017090817102230000_59.3.R121.73","doi-asserted-by":"publisher","DOI":"10.1042\/bj20030852"},{"key":"2017090817102230000_59.3.R121.74","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.3.491"},{"key":"2017090817102230000_59.3.R121.75","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90635-4"},{"key":"2017090817102230000_59.3.R121.76","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/bi401164k","article-title":"pH dependence of amylin fibrillization","volume":"53","author":"Jha","year":"2014","journal-title":"Biochemistry"},{"key":"2017090817102230000_59.3.R121.77","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1430593"},{"key":"2017090817102230000_59.3.R121.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.02.036"},{"key":"2017090817102230000_59.3.R121.79","doi-asserted-by":"publisher","DOI":"10.2337\/diab.39.5.634"},{"key":"2017090817102230000_59.3.R121.80","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.47.4.640"},{"key":"2017090817102230000_59.3.R121.81","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2014.937857"},{"key":"2017090817102230000_59.3.R121.82","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(89)81527-3"},{"key":"2017090817102230000_59.3.R121.83","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C400260200"},{"key":"2017090817102230000_59.3.R121.84","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20009"},{"key":"2017090817102230000_59.3.R121.85","doi-asserted-by":"publisher","DOI":"10.1021\/bi060579z"},{"key":"2017090817102230000_59.3.R121.86","doi-asserted-by":"publisher","DOI":"10.1110\/ps.036350.108"},{"key":"2017090817102230000_59.3.R121.87","doi-asserted-by":"publisher","DOI":"10.1093\/protein\/gzm076"},{"key":"2017090817102230000_59.3.R121.88","doi-asserted-by":"crossref","first-page":"e19273","DOI":"10.7554\/eLife.19273","article-title":"Atomic structures of fibrillar segments of hIAPP suggest tightly mated beta-sheets are important for cytotoxicity","volume":"6","author":"Krotee","year":"2017","journal-title":"eLife"},{"key":"2017090817102230000_59.3.R121.89","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1039\/c3cc41452c","article-title":"A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide","volume":"49","author":"Kumar","year":"2013","journal-title":"Chemical Communications"},{"key":"2017090817102230000_59.3.R121.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.chembiol.2015.01.006"},{"key":"2017090817102230000_59.3.R121.91","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2003.10.045"},{"key":"2017090817102230000_59.3.R121.92","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00125-010-1717-9","article-title":"Differences between amyloid toxicity in alpha and beta cells in human and mouse islets and the role of caspase-3","volume":"53","author":"Law","year":"2010","journal-title":"Diabetologia"},{"key":"2017090817102230000_59.3.R121.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpj.2012.01.039"},{"key":"2017090817102230000_59.3.R121.94","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1046\/j.1365-2265.2001.01244.x","article-title":"The islet amyloid polypeptide (amylin) gene S20G mutation in Chinese subjects: evidence for associations with type 2 diabetes and cholesterol levels","volume":"54","author":"Lee","year":"2001","journal-title":"Clinical Endocrinology"},{"key":"2017090817102230000_59.3.R121.95","doi-asserted-by":"publisher","DOI":"10.1038\/368756a0"},{"key":"2017090817102230000_59.3.R121.96","doi-asserted-by":"publisher","DOI":"10.1021\/bi701427q"},{"key":"2017090817102230000_59.3.R121.97","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3109\/13506120108993820","article-title":"Enhanced in vitro production of amyloid-like fibrils from mutant (S20G) islet amyloid polypeptide","volume":"8","author":"Ma","year":"2001","journal-title":"Amyloid"},{"key":"2017090817102230000_59.3.R121.98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0168-8227(00)00188-1","article-title":"Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance","volume":"50","author":"MacNamara","year":"2000","journal-title":"Diabetes Research and Clinical Practice"},{"key":"2017090817102230000_59.3.R121.99","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200215318"},{"key":"2017090817102230000_59.3.R121.100","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1566"},{"key":"2017090817102230000_59.3.R121.101","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.1.141"},{"key":"2017090817102230000_59.3.R121.102","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1935"},{"key":"2017090817102230000_59.3.R121.103","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.47.3.225"},{"key":"2017090817102230000_59.3.R121.104","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)00887-2"},{"key":"2017090817102230000_59.3.R121.105","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s00125-016-4045-x","article-title":"The S20G substitution in hIAPP is more amyloidogenic and cytotoxic than wild-type hIAPP in mouse islets","volume":"59","author":"Meier","year":"2016","journal-title":"Diabetologia"},{"key":"2017090817102230000_59.3.R121.106","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3304-y"},{"key":"2017090817102230000_59.3.R121.107","doi-asserted-by":"publisher","DOI":"10.1021\/bi100939a"},{"key":"2017090817102230000_59.3.R121.108","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jmb.2010.12.028","article-title":"Inhibition of glycosaminoglycan-mediated amyloid formation by islet amyloid polypeptide and proIAPP processing intermediates","volume":"406","author":"Meng","year":"2011","journal-title":"Journal of Molecular Biology"},{"key":"2017090817102230000_59.3.R121.109","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.4.1988"},{"key":"2017090817102230000_59.3.R121.110","doi-asserted-by":"publisher","DOI":"10.1002\/cbic.200800762"},{"key":"2017090817102230000_59.3.R121.111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2015.11.018","article-title":"Protein disulfide isomerase ameliorates beta-cell dysfunction in pancreatic islets overexpressing human islet amyloid polypeptide","volume":"420","author":"Montane","year":"2016","journal-title":"Molecular and Cellular Endocrinology"},{"key":"2017090817102230000_59.3.R121.112","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1999.3286"},{"key":"2017090817102230000_59.3.R121.113","doi-asserted-by":"publisher","DOI":"10.2337\/diab.43.2.329"},{"key":"2017090817102230000_59.3.R121.114","doi-asserted-by":"publisher","DOI":"10.1210\/jc.79.1.290"},{"key":"2017090817102230000_59.3.R121.115","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.02549"},{"key":"2017090817102230000_59.3.R121.116","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.631697"},{"key":"2017090817102230000_59.3.R121.117","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/dom.12873","article-title":"Dual role of interleukin-1beta in islet amyloid formation and its beta-cell toxicity: implications for type 2 diabetes and islet transplantation","volume":"5","author":"Park","year":"2017","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"2017090817102230000_59.3.R121.118","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0206-7"},{"key":"2017090817102230000_59.3.R121.119","doi-asserted-by":"crossref","first-page":"21274","DOI":"10.1038\/srep21274","article-title":"Pancreatic beta-cell membrane fluidity and toxicity induced by human islet amyloid polypeptide species","volume":"6","author":"Pilkington","year":"2016","journal-title":"Scientific Reports"},{"key":"2017090817102230000_59.3.R121.120","doi-asserted-by":"publisher","DOI":"10.1021\/bi048582a"},{"key":"2017090817102230000_59.3.R121.121","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909024107"},{"key":"2017090817102230000_59.3.R121.122","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2009.02.013"},{"key":"2017090817102230000_59.3.R121.123","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/ajt.13134","article-title":"Amyloid formation in human islets is enhanced by heparin and inhibited by heparinase","volume":"15","author":"Potter","year":"2015","journal-title":"American Journal of Transplantation"},{"key":"2017090817102230000_59.3.R121.124","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3390\/genes6010087","article-title":"Genetics of type 2 diabetes-pitfalls and possibilities","volume":"6","author":"Prasad","year":"2015","journal-title":"Genes"},{"key":"2017090817102230000_59.3.R121.125","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1410-z"},{"key":"2017090817102230000_59.3.R121.126","doi-asserted-by":"publisher","DOI":"10.1038\/nature20416"},{"key":"2017090817102230000_59.3.R121.127","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0734"},{"key":"2017090817102230000_59.3.R121.128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI71981"},{"key":"2017090817102230000_59.3.R121.129","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1153-1"},{"key":"2017090817102230000_59.3.R121.130","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/S0002-9440(10)64848-1","article-title":"S20G mutant amylin exhibits increased in vitro amyloidogenicity and increased intracellular cytotoxicity compared to wild-type amylin","volume":"157","author":"Sakagashira","year":"2000","journal-title":"American Journal of Pathology"},{"key":"2017090817102230000_59.3.R121.131","doi-asserted-by":"publisher","DOI":"10.2337\/diab.45.9.1279"},{"key":"2017090817102230000_59.3.R121.132","doi-asserted-by":"publisher","DOI":"10.1007\/BF00500385"},{"key":"2017090817102230000_59.3.R121.133","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF00213820","article-title":"Lysosomes and pancreatic islet function. A quantitative estimation of crinophagy in the mouse pancreatic B-cell","volume":"252","author":"Schnell","year":"1988","journal-title":"Cell and Tissue Research"},{"key":"2017090817102230000_59.3.R121.134","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2836(02)00164-X"},{"key":"2017090817102230000_59.3.R121.135","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2460"},{"key":"2017090817102230000_59.3.R121.136","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/1873-3468.12261","article-title":"Peptide Inhibitors of the amyloidogenesis of IAPP: verification of the hairpin-binding geometry hypothesis","volume":"590","author":"Sivanesam","year":"2016","journal-title":"FEBS Letters"},{"key":"2017090817102230000_59.3.R121.137","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3233(08)60320-4"},{"key":"2017090817102230000_59.3.R121.138","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2312"},{"key":"2017090817102230000_59.3.R121.139","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1464-5491.1992.tb01830.x","article-title":"Measurement of insulin secretion in type 2 diabetes: problems and pitfalls","volume":"9","author":"Temple","year":"1992","journal-title":"Diabetic Medicine"},{"key":"2017090817102230000_59.3.R121.140","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/BF01605927","article-title":"Islet amyloid polypeptide in insulinoma and in the islets of the pancreas of non-diabetic and diabetic subjects","volume":"418","author":"Toshimori","year":"1991","journal-title":"Virchows Archivs"},{"key":"2017090817102230000_59.3.R121.141","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.240762"},{"key":"2017090817102230000_59.3.R121.142","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1185-7"},{"key":"2017090817102230000_59.3.R121.143","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.11.2514"},{"key":"2017090817102230000_59.3.R121.144","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.3.534"},{"key":"2017090817102230000_59.3.R121.145","doi-asserted-by":"crossref","first-page":"5876","DOI":"10.1021\/bi500592p","article-title":"Rationally designed, nontoxic, nonamyloidogenic analogues of human islet amyloid polypeptide with improved solubility","volume":"53","author":"Wang","year":"2014","journal-title":"Biochemistry"},{"key":"2017090817102230000_59.3.R121.146","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296991"},{"key":"2017090817102230000_59.3.R121.147","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31823e46ef"},{"key":"2017090817102230000_59.3.R121.148","doi-asserted-by":"publisher","DOI":"10.1517\/03009734000000014"},{"key":"2017090817102230000_59.3.R121.149","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00549079","article-title":"Fine structure of islets of Langerhans in insular amyloidosis","volume":"359","author":"Westermark","year":"1973","journal-title":"Virchows Archivs"},{"key":"2017090817102230000_59.3.R121.150","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00042.2009"},{"key":"2017090817102230000_59.3.R121.151","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.13.5036"},{"key":"2017090817102230000_59.3.R121.152","first-page":"291","article-title":"The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults","volume":"81","author":"Westermark","year":"1973","journal-title":"Acta Pathologica et Microbiologica Scandinavica: Section A"},{"key":"2017090817102230000_59.3.R121.153","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)01512-4"},{"key":"2017090817102230000_59.3.R121.154","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002854"},{"key":"2017090817102230000_59.3.R121.155","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/dom.12529","article-title":"Islet amyloid inhibitors improve glucose homeostasis in a transgenic mouse model of type 2 diabetes","volume":"17","author":"Wijesekara","year":"2015","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"2017090817102230000_59.3.R121.156","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2009.07.077"},{"key":"2017090817102230000_59.3.R121.157","doi-asserted-by":"publisher","DOI":"10.1110\/ps.062486907"},{"key":"2017090817102230000_59.3.R121.158","doi-asserted-by":"publisher","DOI":"10.1110\/ps.036509.108"},{"key":"2017090817102230000_59.3.R121.159","doi-asserted-by":"publisher","DOI":"10.1002\/pro.145"},{"key":"2017090817102230000_59.3.R121.160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/ja406831n","article-title":"Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors","volume":"136","author":"Young","year":"2014","journal-title":"Journal of the American Chemical Society"},{"key":"2017090817102230000_59.3.R121.161","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nchem.2129","article-title":"Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry","volume":"7","author":"Young","year":"2015","journal-title":"Nature Chemistry"},{"key":"2017090817102230000_59.3.R121.162","doi-asserted-by":"publisher","DOI":"10.1096\/fj.14-251744"},{"key":"2017090817102230000_59.3.R121.163","doi-asserted-by":"publisher","DOI":"10.2337\/db07-0849"},{"key":"2017090817102230000_59.3.R121.164","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M308244200"},{"key":"2017090817102230000_59.3.R121.165","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/acs.biochem.6b01016","article-title":"Islet amyloid polypeptide membrane interactions: effects of membrane composition","volume":"56","author":"Zhang","year":"2017","journal-title":"Biochemistry"},{"key":"2017090817102230000_59.3.R121.166","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.trsl.2008.10.009","article-title":"Amyloid oligomers in diabetic and nondiabetic human pancreas","volume":"153","author":"Zhao","year":"2009","journal-title":"Translational Research"},{"key":"2017090817102230000_59.3.R121.167","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jinorgbio.2017.02.008","article-title":"Disaggregation of human islet amyloid polypeptide fibril formation by ruthenium polypyridyl complexes","volume":"170","author":"Zhu","year":"2017","journal-title":"Journal of Inorganic Biochemistry"},{"key":"2017090817102230000_59.3.R121.168","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1264"},{"key":"2017090817102230000_59.3.R121.169","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1671-6"}],"container-title":["Journal of Molecular Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/jme.bioscientifica.com\/view\/journals\/jme\/59\/3\/JME-17-0105.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1530\/JME-17-0105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:53:14Z","timestamp":1784555594000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/jme\/article\/59\/3\/R121-R140\/14203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":169,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1530\/jme-17-0105","relation":{},"ISSN":["0952-5041","1479-6813"],"issn-type":[{"value":"0952-5041","type":"print"},{"value":"1479-6813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10]]}}}